0001225208-24-002572.txt : 20240220 0001225208-24-002572.hdr.sgml : 20240220 20240220210335 ACCESSION NUMBER: 0001225208-24-002572 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240216 FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brown Vance R CENTRAL INDEX KEY: 0001868243 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 24656134 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0508 4 2024-02-16 0000885725 BOSTON SCIENTIFIC CORP BSX 0001868243 Brown Vance R 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 SVP, GC and Corp. Secretary 0 Common Stock 2024-02-16 4 M 0 1838.0000 0.0000 A 31637.0000 D Common Stock 2024-02-16 4 F 0 540.0000 65.8200 D 31097.0000 D Common Stock 2024-02-17 4 M 0 1000.0000 0.0000 A 32097.0000 D Common Stock 2024-02-17 4 F 0 294.0000 65.8200 D 31803.0000 D Common Stock 2024-02-18 4 M 0 741.0000 0.0000 A 32544.0000 D Common Stock 2024-02-18 4 F 0 218.0000 65.8200 D 32326.0000 D Restricted Stock Units 2024-02-16 4 M 0 1838.0000 0.0000 D 2026-02-16 Common Stock 1838.0000 3678.0000 D Restricted Stock Units 2024-02-17 4 M 0 1000.0000 0.0000 D 2025-02-17 Common Stock 1000.0000 1000.0000 D Deferred Stock Units 2024-02-18 4 M 0 741.0000 0.0000 D 2024-02-18 Common Stock 741.0000 0.0000 D Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant. /s/ Susan Thompson, Attorney-in-Fact 2024-02-20